Evidence map›Paper›PMID 29460114›Full record

ArticleNeurotoxicity research2018

Peripheral Administration of Tetanus Toxin Hc Fragment Prevents MPP

Natalia Moreno-Galarza, Liliana Mendieta, Victoria Palafox-Sánchez, Mireia Herrando-Grabulosa, Carles Gil, Daniel I Limón, José Aguilera

Abstract read
PubMed Publisher
In one paragraph

Article in Neurotoxicity research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Natalia Moreno-GalarzaInstitut de Neurociències and Departament de Bioquímica i de Biologia Molecular, Facultat de Medicina, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193, Barcelona, Spain.
Liliana MendietaLaboratorio de Neurofarmacología, FCQ-Benemérita Universidad Autónoma de Puebla, Puebla, Mexico.
Victoria Palafox-SánchezLaboratorio de Neurofarmacología, FCQ-Benemérita Universidad Autónoma de Puebla, Puebla, Mexico.
Mireia Herrando-GrabulosaInstitut de Neurociències and Departament de Bioquímica i de Biologia Molecular, Facultat de Medicina, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193, Barcelona, Spain.
Carles GilInstitut de Neurociències and Departament de Bioquímica i de Biologia Molecular, Facultat de Medicina, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193, Barcelona, Spain.
Daniel I LimónLaboratorio de Neurofarmacología, FCQ-Benemérita Universidad Autónoma de Puebla, Puebla, Mexico.
José AguileraInstitut de Neurociències and Departament de Bioquímica i de Biologia Molecular, Facultat de Medicina, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193, Barcelona, Spain. jose.aguilera@uab.cat.
Benemérita Universidad Autónoma de Puebla · MXUniversitat Autònoma de Barcelona · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ES

Funding

Ministerio de Ciencia, Tecnología e Innovación (Dirección General de Investigación) SAF2016-80027-RMinisterior de Ciencia e Innovación (Dirección General de Investigación) SAF2009-13626Secretaría de Educación Pública (MX) PRODEP-SEP (PTC-472)
6 · The paper itself

Abstract

Several studies have shown that intrastriatal application of 1-methyl-4-phenylpyridinium (MPP

Indexed as

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine3,4-Dihydroxyphenylacetic AcidAnalysis of VarianceAnimalsCorpus StriatumDisease Models, AnimalDopamineDopamine Plasma Membrane Transport ProteinsDose-Response Relationship, DrugDrug Administration RoutesDrug Administration ScheduleFunctional LateralityHomovanillic AcidMaleMovementMPTP Poisoning1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine3,4-Dihydroxyphenylacetic AcidDopamineDopamine Plasma Membrane Transport ProteinsHomovanillic AcidNeuroprotective AgentsPeptide FragmentsTetanus Toxintetanus toxin fragment CTritiumTyrosine 3-Monooxygenase1-Methyl-4-phenylpyridiniumCarboxyl-terminal domain of tetanus toxinDopamineNeuroprotectionParkinson’s diseaseTyrosine hydroxylase

Identifiers

PMID29460114
OpenAlexW2788147463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.